Novartis’ TREM2 drug fails Phase 2 ALS trial
Novartis' ALS drug fails in mid-stage trial, halting development
12 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 12 separate news trends connected to Clinical Trial, spanning August 5, 2026 through September 16, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 91 article observations and 88 source signals, led by Health, Business coverage. Use it to compare how individual events emerged, spread and changed over time.
Novartis' ALS drug fails in mid-stage trial, halting development
A simple laugh may ease the breathlessness of COPD, turning humor into a surprising medical aid.
A childhood‑obesity drug once reserved for adults now shows weight‑loss promise in kids as young as six.
Arthritis drug unexpectedly reverses severe baldness in patients with alopecia.
New sham‑controlled trial shows AFib ablation cuts irregular beats but fails to lift patients’ quality of life.
BioNTech and Roche have halted a mid-stage cancer vaccine trial after more deaths occurred in the treatment group than in the control group.
A cancer therapy has shown promise in treating severe rheumatoid arthritis, offering new hope to patients.
A clinical trial has found that the keto diet may have unique benefits for liver health compared to other popular weight-loss diets.
Shares of Moderna have doubled after its cancer vaccine trial with Merck met key endpoints.
Moderna's stock surges as a melanoma vaccine developed with Merck shows promise in a large trial
A small trial of fecal transplants shows promise in treating food allergies, but the method is not yet widely accepted.
Moderna's Phase 1 Ebola vaccine trial begins as the outbreak in DR Congo continues to spread